Status:

RECRUITING

Allopurinol Improves Heart Function in African Americans With Resistant Hypertension

Lead Sponsor:

VA Office of Research and Development

Conditions:

Heart Failure Preserved Ejection Fraction

Resistant Hypertension

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

African American adults in the United States have the highest prevalence rate of high blood pressure (hypertension) and heart failure in the world. African Americans with treatment resistant hypertens...

Detailed Description

Hypertension among African American adults in the United States has one of the highest prevalence rates in the world and is related to adverse changes in left ventricular (LV) structure and function. ...

Eligibility Criteria

Inclusion Criteria:

In order to be eligible to participate in this study, an individual must meet all of the following criteria:

  1. Veteran
  2. African American
  3. Resistant hypertension diagnosis (defined as blood pressure greater than 140/90 mmHg at 2 clinic visits despite the use of 3 antihypertensive medications at pharmacologically effective doses)
  4. Locale - Birmingham, AL and surrounding areas

Exclusion Criteria:

  1. History of heart failure
  2. Chronic kidney disease (estimated creatinine clearance < 60 ml/min)
  3. Chronic steroid therapy
  4. Known coronary artery disease
  5. Known causes of secondary hypertension
  6. Already taking Allopurinol

Magnetic Resonance Imaging Exclusion

  1. Claustrophobia
  2. Cardiac implantable electronic device (permanent pacemaker and/or intracardiac defibrillator)
  3. Metal clips and/devices or other item that specifically prohibit safe CMR

Key Trial Info

Start Date :

September 30 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 31 2026

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT05888233

Start Date

September 30 2024

End Date

May 31 2026

Last Update

January 22 2026

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Birmingham VA Medical Center, Birmingham, AL

Birmingham, Alabama, United States, 35233-1927